Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance

Ironwood Pharmaceuticals Inc (IRWD)

We couldn't retrieve the full text for this release. Read it on the company's site.